Immunology and Microbiology
Mouse
100%
B Cell
88%
Mediator
85%
CD3 Antigen
77%
Allogeneic Hematopoietic Stem Cell Transplantation
77%
Precursor
77%
Neutrophil Granulocyte
77%
M2 Macrophages
77%
Bone Marrow Transplantation
77%
Glucocorticoid
77%
Natural Killer Cell
77%
Graft-Versus-Host Disease
77%
Hematopoietic Stem Cell Transplantation
74%
Autoimmune Disease
44%
Macrophage
38%
Peripheral Blood Mononuclear Cell
33%
Dexamethasone
31%
Cell Line
31%
Adoptive Immunotherapy
22%
Neutrophil
22%
T Cell
22%
CD5
22%
Major Histocompatibility Complex
22%
CD23
22%
Bagg Albino Mouse
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
15%
CD4
11%
C-Type Lectin
11%
Cell Population
11%
Tumor Necrosis Factor Alpha
11%
Murphy Roths Large Lymphoproliferative Mouse
11%
Acute Graft Versus Host Disease
11%
Interferon Gamma
11%
Neutrophil Count
11%
Lymphoma Cell Line
11%
Peritoneal Cavity
11%
Autoantibodies
11%
Lupus Erythematosus
11%
Congenic Strain
11%
C57BL 10 Mouse
11%
CD8
11%
Interleukin 10
11%
Surface Property
11%
Cell Contact
9%
Tissue Regeneration
9%
Splenocyte
9%
T Cell Proliferation
9%
Immunomodulation
9%
Antiinflammatory Activity
9%
Mononuclear Cell
9%
Medicine and Dentistry
Vasculotropin
77%
Graft Versus Host Reaction
77%
Metastatic Carcinoma
77%
Nafamstat Mesilate
77%
Allogeneic Hematopoietic Stem Cell Transplantation
77%
Cleft Palate
77%
Ganglioneuroblastoma
77%
M2 Macrophages
77%
Tracheal Anomaly
38%
Macrophage
38%
Thumb Malformation
38%
SPRED1
31%
Cell Proliferation
19%
Hematopoietic Stem Cell Transplantation
19%
Neuroblastoma Cell
19%
Persistent Truncus Arteriosus
15%
Genetic Counseling
15%
Surgery
15%
Cytokine
9%
T Cell Proliferation
9%
Cell Migration
9%
Cell Contact
9%
Cell Therapy
9%
Mononuclear Cell
9%
Antiinflammatory Activity
9%
Tissue Regeneration
9%
Serine Proteinase
9%
Wound Healing
9%
Gut
9%
WST-8 Assay
9%
Immunomodulation
9%
Enzyme Linked Immunosorbent Assay
9%
Cell Culture
9%
Combination Therapy
9%
Disease
9%
Anti-Inflammatory Drug
9%
Disease Severity
9%
In Vitro
9%
Western Blot
9%
Pathophysiology
9%
Keyphrases
Graft-versus-host Disease (GvHD)
77%
Donor-derived
77%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
77%
M2 Macrophages
77%
VACTERL Association
77%
Vascular Endothelial Growth Factor Inhibition
77%
Macrophages
38%
MEIS2
31%
Hematopoietic Stem Cell Transplantation
19%
Bone Marrow Cells
19%
BCL2L11
15%
Dexamethasone Resistance
15%
Surgical Genetics
15%
Genomic Evaluation
15%
Oral Sustained Release
12%
Liver Cytochrome P450
12%
Biological Father
12%
Graft-versus-tumor
11%
Ly49
11%
Licensing Process
11%
Natural Killer Subsets
11%
Anal Anomalies
11%
Kidney Morphogenesis
11%
Thumbs Anomalies
11%
Alternatively Activated
9%
Immune-suppressive
9%
Bone Marrow
9%
Liver
9%
Bone Marrow Mononuclear Cells
9%
Cell-based
9%
Balb C Mice
9%
Fatal Complication
9%
Classically Activated
9%
Cell-cell Communication
9%
Tissue Regeneration
9%
T Cell Proliferation
9%
Splenocytes
9%
Immunomodulation
9%
Protective Effect
9%
Disease Severity
9%
Anti-inflammatory Effect
9%
Pathophysiology
9%
Donor T Cell
9%
Neuroblastoma Metastases
9%
Improved Survival
9%
Disease Survival
9%
Prolonged Survival
9%
CD5 Antigen
7%
Hypotonic Shock
7%
Age Progression
7%
